Your browser doesn't support javascript.
loading
Oligodendrocytes produce amyloid-ß and contribute to plaque formation alongside neurons in Alzheimer's disease model mice.
Sasmita, Andrew Octavian; Depp, Constanze; Nazarenko, Taisiia; Sun, Ting; Siems, Sophie B; Ong, Erinne Cherisse; Nkeh, Yakum B; Böhler, Carolin; Yu, Xuan; Bues, Bastian; Evangelista, Lisa; Mao, Shuying; Morgado, Barbara; Wu, Zoe; Ruhwedel, Torben; Subramanian, Swati; Börensen, Friederike; Overhoff, Katharina; Spieth, Lena; Berghoff, Stefan A; Sadleir, Katherine Rose; Vassar, Robert; Eggert, Simone; Goebbels, Sandra; Saito, Takashi; Saido, Takaomi; Saher, Gesine; Möbius, Wiebke; Castelo-Branco, Gonçalo; Klafki, Hans-Wolfgang; Wirths, Oliver; Wiltfang, Jens; Jäkel, Sarah; Yan, Riqiang; Nave, Klaus-Armin.
Afiliação
  • Sasmita AO; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany. sasmita@mpinat.mpg.de.
  • Depp C; International Max Planck Research School for Neurosciences, Göttingen, Germany. sasmita@mpinat.mpg.de.
  • Nazarenko T; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany. depp@mpinat.mpg.de.
  • Sun T; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Siems SB; International Max Planck Research School for Neurosciences, Göttingen, Germany.
  • Ong EC; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Nkeh YB; Laboratory of Molecular Neurobiology, Department of Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Böhler C; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Yu X; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Bues B; International Max Planck Research School for Neurosciences, Göttingen, Germany.
  • Evangelista L; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Mao S; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Morgado B; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Wu Z; School of Biochemistry and Cell Biology, Biosciences Institute, University College Cork, Cork, Ireland.
  • Ruhwedel T; Institute for Stroke and Dementia Research, Klinikum Der Universität München, Ludwig-Maximilians-Universität, Munich, Germany.
  • Subramanian S; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Börensen F; Department of Psychiatry and Psychotherapy, University Medical Center, Georg-August University, Göttingen, Germany.
  • Overhoff K; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Spieth L; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Berghoff SA; Electron Microscopy Core Unit, Max Planck Institute Multidisciplinary Sciences, Göttingen, Germany.
  • Sadleir KR; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Vassar R; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Eggert S; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Goebbels S; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Saito T; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Saido T; Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Saher G; Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Möbius W; Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Castelo-Branco G; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Klafki HW; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Wirths O; Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science Wako, Saitama, Japan.
  • Wiltfang J; Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science Wako, Saitama, Japan.
  • Jäkel S; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Yan R; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
  • Nave KA; Electron Microscopy Core Unit, Max Planck Institute Multidisciplinary Sciences, Göttingen, Germany.
Nat Neurosci ; 2024 Aug 05.
Article em En | MEDLINE | ID: mdl-39103558
ABSTRACT
Amyloid-ß (Aß) is thought to be neuronally derived in Alzheimer's disease (AD). However, transcripts of amyloid precursor protein (APP) and amyloidogenic enzymes are equally abundant in oligodendrocytes (OLs). By cell-type-specific deletion of Bace1 in a humanized knock-in AD model, APPNLGF, we demonstrate that OLs and neurons contribute to Aß plaque burden. For rapid plaque seeding, excitatory projection neurons must provide a threshold level of Aß. Ultimately, our findings are relevant for AD prevention and therapeutic strategies.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nat Neurosci Assunto da revista: NEUROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nat Neurosci Assunto da revista: NEUROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha